Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Property:HasDocument

From GxPlex

Jump to: navigation, search

Page

Links a Reference: page to its parent Document: page.

previous 202050100250500next 20
Showing 20 pages using this property.
E
EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 3 +
EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018  +
EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 3.5.2 +
EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018  +
EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 3.5.3 +
EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018  +
EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 5.1 - 5.2-001 +
EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018  +
EU Recommendations of the expert group - Risk proportionate approaches in clinical trials 25-Apr-2017 4.5 +
EU Recommendations of the expert group - Risk proportionate approaches in clinical trials 25-Apr-2017  +
U
USA 21 CFR Part 312 09-Apr-2025 § 312.62 +
USA 21 CFR Part 312 09-Apr-2025  +
USA 21 CFR Part 312 09-Apr-2025 § 312.57-001 +
USA 21 CFR Part 312 09-Apr-2025  +
USA 21 CFR Part 812 09-Apr-2025 Subpart G +
USA 21 CFR Part 812 09-Apr-2025  +
W
WMA Declaration of Helsinki 2024 Paragraph 22 +
WMA Declaration of Helsinki 2024  +
I
ICH ICH E6 Guideline R3 (2025) Appendix B +
ICH ICH E6 Guideline R3 (2025)  +
ICH ICH E6 Guideline R3 (2025) II 7.4 +
ICH ICH E6 Guideline R3 (2025)  +
W
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - protocol +
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995  +
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 2 +
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995  +
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Appendix 2 +
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995  +
WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005 Page 28-29 +
WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005  +
I
ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 Annex A - CIP +
ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020  +
N
N.A. SPIRIT 2013 - Chan et al. 2013 - +
N.A. SPIRIT 2013 - Chan et al. 2013  +
I
ICH ICH E8 Guideline R1 (2021) 5. +
ICH ICH E8 Guideline R1 (2021)  +
E
EU EMA/298712/2022 - Complex clinical trials – Questions and answers 23-May-2022 Glossary +
EU EMA/298712/2022 - Complex clinical trials – Questions and answers 23-May-2022  +
EU Regulation (EU) No 520/2012 - performance of pharmacovigilance activities 20-Jun-12 Annex III 1. +
EU Regulation (EU) No 520/2012 - performance of pharmacovigilance activities 20-Jun-12  +
Retrieved from "https://gxplex.org/index.php?title=Property:HasDocument&oldid=6216"